71 related articles for article (PubMed ID: 38649928)
41. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review.
McLoughlin EC; O'Boyle NM
Pharmaceuticals (Basel); 2020 Jan; 13(1):. PubMed ID: 31947889
[TBL] [Abstract][Full Text] [Related]
42. Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles.
AbouAitah K; Hassan HA; Swiderska-Sroda A; Gohar L; Shaker OG; Wojnarowicz J; Opalinska A; Smalc-Koziorowska J; Gierlotka S; Lojkowski W
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936103
[TBL] [Abstract][Full Text] [Related]
43. NLRP3 inflammasome activation by estrogen promotes the progression of human endometrial cancer.
Liu SG; Wu XX; Hua T; Xin XY; Feng DL; Chi SQ; Wang XX; Wang HB
Onco Targets Ther; 2019; 12():6927-6936. PubMed ID: 31695408
[TBL] [Abstract][Full Text] [Related]
44. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.
Chuang JP; Lee JC; Leu TH; Hidajah AC; Chang YH; Li CY
BMJ Open; 2019 Oct; 9(10):e028892. PubMed ID: 31601586
[TBL] [Abstract][Full Text] [Related]
45. Idiopathic pulmonary fibrosis and GERD: links and risks.
Ghisa M; Marinelli C; Savarino V; Savarino E
Ther Clin Risk Manag; 2019; 15():1081-1093. PubMed ID: 31564886
[TBL] [Abstract][Full Text] [Related]
46. The Association Between Usage of Colchicine and Pneumonia: A Nationwide, Population-Based Cohort Study.
Tsai TL; Wei JC; Wu YT; Ku YH; Lu KL; Wang YH; Chiou JY
Front Pharmacol; 2019; 10():908. PubMed ID: 31474864
[No Abstract] [Full Text] [Related]
47. Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells.
Lee HE; Lee JY; Yang G; Kang HC; Cho YY; Lee HS; Lee JY
Sci Rep; 2019 Aug; 9(1):12277. PubMed ID: 31439870
[TBL] [Abstract][Full Text] [Related]
48. High Glucose Promotes Human Glioblastoma Cell Growth by Increasing the Expression and Function of Chemoattractant and Growth Factor Receptors.
Bao Z; Chen K; Krepel S; Tang P; Gong W; Zhang M; Liang W; Trivett A; Zhou M; Wang JM
Transl Oncol; 2019 Sep; 12(9):1155-1163. PubMed ID: 31207546
[TBL] [Abstract][Full Text] [Related]
49. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
50. A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0.
Russell B; Garmo H; Beckmann K; Stattin P; Adolfsson J; Van Hemelrijck M
PLoS One; 2018; 13(4):e0195690. PubMed ID: 29649268
[TBL] [Abstract][Full Text] [Related]
51. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Martínez GJ; Celermajer DS; Patel S
Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
[TBL] [Abstract][Full Text] [Related]
52. Anticancer Effects of Colchicine on Hypopharyngeal Cancer.
Cho JH; Joo YH; Shin EY; Park EJ; Kim MS
Anticancer Res; 2017 Nov; 37(11):6269-6280. PubMed ID: 29061810
[TBL] [Abstract][Full Text] [Related]
53. Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan.
Kao WH; Hong JH; See LC; Yu HP; Hsu JT; Chou IJ; Chou WC; Chiou MJ; Wang CC; Kuo CF
Pharmacoepidemiol Drug Saf; 2018 Oct; 27(10):1060-1066. PubMed ID: 28815803
[TBL] [Abstract][Full Text] [Related]
54. FDA-approved medications that impair human spermatogenesis.
Ding J; Shang X; Zhang Z; Jing H; Shao J; Fei Q; Rayburn ER; Li H
Oncotarget; 2017 Feb; 8(6):10714-10725. PubMed ID: 27801671
[TBL] [Abstract][Full Text] [Related]
55. Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome.
Otani K; Watanabe T; Shimada S; Takeda S; Itani S; Higashimori A; Nadatani Y; Nagami Y; Tanaka F; Kamata N; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
Sci Rep; 2016 Sep; 6():32587. PubMed ID: 27585971
[TBL] [Abstract][Full Text] [Related]
56. Trends of CT utilisation in an emergency department in Taiwan: a 5-year retrospective study.
Hu SY; Hsieh MS; Lin MY; Hsu CY; Lin TC; How CK; Wang CY; Tsai JC; Wu YH; Chang YZ
BMJ Open; 2016 Jun; 6(6):e010973. PubMed ID: 27279477
[TBL] [Abstract][Full Text] [Related]
57. Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases: A Nationwide Population-Based Dynamic Cohort Study in Taiwan.
Yu KH; Kuo CF; Huang LH; Huang WK; See LC
Medicine (Baltimore); 2016 May; 95(18):e3540. PubMed ID: 27149461
[TBL] [Abstract][Full Text] [Related]
58. Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines.
Lin ZY; Kuo CH; Wu DC; Chuang WL
Kaohsiung J Med Sci; 2016 Feb; 32(2):68-73. PubMed ID: 26944324
[TBL] [Abstract][Full Text] [Related]
59. Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.
Kuo MC; Chang SJ; Hsieh MC
Medicine (Baltimore); 2015 Dec; 94(50):e1570. PubMed ID: 26683907
[TBL] [Abstract][Full Text] [Related]
60. Increased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 Subjects.
Wang W; Xu D; Wang B; Yan S; Wang X; Yin Y; Wang X; Sun B; Sun X
Mediators Inflamm; 2015; 2015():680853. PubMed ID: 26504360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
